Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Artrya collaborates with healthcare facilities that treat chest pain patients to introduce innovative cardiovascular care models powered by artificial intelligence. This approach seamlessly incorporates high-prognostic plaque characteristics into the assessment of coronary artery disease. It enables swift evaluations of chest pain patients in both emergency and primary care environments. Our vision is a society free from the burden of heart attacks. Leveraging AI-generated insights from coronary computed tomography angiography (CCTA), we can rapidly and accurately classify chest pain patients based on the type and quantity of arterial plaque identified. This allows for quick identification of individuals with little to no coronary artery disease, ensuring that no underlying plaque issues could lead to significant cardiac events in the future. By recognizing early indicators of potential heart attacks, we can effectively confirm at-risk patients with acute or unusual chest pain who may require additional investigation and treatment. Ultimately, this advancement aims to enhance patient outcomes and foster a healthier community.
Description
Individuals globally are plagued by intricate illnesses and a wide array of symptoms. Yet, they all have one crucial requirement in common: the urgent demand for the quicker creation of safer and more efficient treatments. Owkin’s goal is to enable researchers in hospitals, universities, and pharmaceutical firms to comprehend the reasons behind variations in drug effectiveness among patients, streamline the drug development process, and pinpoint the optimal medication for each individual to enhance therapeutic results. Central to Owkin's research ecosystem is Owkin Loop, which links medical researchers with high-quality datasets sourced from top academic research institutions worldwide. This innovative platform is driven by two primary elements of Owkin's Software Stack: Owkin Studio, a machine learning platform, and Owkin Connect, which serves as a federated learning framework. Additionally, Owkin is actively engaged in medical research collaborations across various fields, including Oncology, Immunology, and Cardiovascular diseases, showcasing the breadth of its commitment to improving patient care. Their collaborative efforts reflect a dedication to transforming healthcare through advanced technology and data-driven insights.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Artrya
Country
Australia
Website
www.artrya.com
Vendor Details
Company Name
Owkin
Founded
2016
Country
United States
Website
owkin.com
Product Features
Product Features
Machine Learning
Deep Learning
ML Algorithm Library
Model Training
Natural Language Processing (NLP)
Predictive Modeling
Statistical / Mathematical Tools
Templates
Visualization